# Items by Jennison, Christopher

Up a level |

Number of items:

**34**.Tamhane, A. C., Gou, J., Jennison, C., Mehta, C. R. and Curto, T., 2017. Forthcoming. A gatekeeping procedure to test a primary and a secondary endpoint in a group sequential design with multiple interim looks.

*Biometrics*Parke, T., Marchenko, O., Anisimov, V., Ivanova, A., Jennison, C., Perevozskaya, I. and Song, G., 2017. Comparing oncology clinical programs by use of innovative designs and expected net present value optimization:which adaptive approach leads to the best result?

*Journal of Biopharmaceutical Statistics*Wason, J., Stallard, N., Bowden, J. and Jennison, C., 2017. A multi-stage drop-the-losers design for multi-arm clinical trials.

*Statistical Methods in Medical Research*, 26 (1), pp. 508-524.Jennison, C. and Turnbull, B. W., 2015. Adaptive sample size modification in clinical trials:start small then ask for more?

*Statistics in Medicine*, 34 (29), pp. 3793-3810.Jennison, C. and Hampson, L., 2015. Optimising the Data Combination Rule for Seamless Phase II/III Clinical Trials.

*Statistics in Medicine*, 34 (1), pp. 39-58.Stone, A., Macpherson, E., Smith, A. and Jennison, C., 2015. Model free audit methodology for bias evaluation of tumour progression in oncology.

*Pharmaceutical Statistics*, 14 (6), pp. 455-463.Jennison, C., Antonijevic, Z., Bolognese, J., Burman, C.-F., Chuang-Stein, C., Kimber, M., Marchenko, O., Patel, N. and Pinheiro, J., 2015. Impact of Phase 2b strategies on optimization of drug development programs.

*In*:*Optimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy.*Heidelberg: Springer, pp. 83-103.Zhou, K., Donnelly, L.A., Morris, A.D., Franks, P.W., Jennison, C., Palmer, C.N.A. and Pearson, E.R., 2014. Clinical and genetic determinants of progression of type 2 diabetes:A direct study.

*Diabetes Care*, 37 (3), pp. 718-724.Hampson, L. V. and Jennison, C., 2013. Group sequential tests for delayed responses (with discussion).

*Journal of the Royal Statistical Society, Series B (Statistical Methodology)*, 75 (1), pp. 3-54.Jennison, C. and Turnbull, B. W., 2013. Interim monitoring of clinical trials:decision theory, dynamic programming and optimal stopping.

*Kuwait Journal of Science*, 40 (2), pp. 43-59.Jenkins, M., Stone, A. and Jennison, C., 2011. An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints.

*Pharmaceutical Statistics*, 10 (4), pp. 347-356.Khorsheed, E., Hurn, M. and Jennison, C., 2011. Mapping electron density in the ionosphere: a principal component MCMC algorithm.

*Computational Statistics & Data Analysis*, 55 (1), pp. 338-352.Al-Awadhi, F., Hurn, M. and Jennison, C., 2011. Three-dimensional Bayesian image analysis and confocal microscopy.

*Journal of Applied Statistics*, 38 (1), pp. 29-46.Ohrn, F. and Jennison, C., 2010. Optimal group-sequential designs for simultaneous testing of superiority and non-inferiority.

*Statistics in Medicine*, 29 (7-8), pp. 743-759.Jennison, C. and Turnbull, B. W., 2007. Adaptive seamless designs: Selection and prospective testing of hypotheses.

*Journal of Biopharmaceutical Statistics*, 17 (6), pp. 1135-1161.Jennison, C. and Turnbull, B. W., 2006. Efficient group sequential designs when there are several effect sizes under consideration.

*Statistics in Medicine*, 25 (6), pp. 917-932.Jennison, C. and Turnbull, B. W., 2006. Adaptive and nonadaptive group sequential tests.

*Biometrika*, 93 (1), pp. 1-21.Jennison, C. and Turnbull, B. W., 2006. Are flexible designs sound? Discussion.

*Biometrics*, 62 (3), pp. 670-673.Jennison, C. and Turnbull, B. W., 2006. Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: Opportunities and limitations.

*Biometrical Journal*, 48 (4), pp. 650-655.Jennison, C. and Turnbull, B. W., 2006. Discussion of "Executive Summary of the PhRMA Working Group on adaptive designs in clinical drug development".

*Journal of Biopharmaceutical Statistics*, 16 May-Jun (3), pp. 293-298.Jennison, C. and Turnbull, B. W., 2005. Meta-analyses and adaptive group sequential designs in the clinical development process.

*Journal of Biopharmaceutical Statistics*, 15 (4), pp. 537-558.Al-Awadhi, F., Jennison, C. and Hurn, M., 2004. Statistical image analysis for a confocal microscopy two-dimensional section of cartilage growth.

*Journal of the Royal Statistical Society Series C-Applied Statistics*, 53 (1), pp. 31-49.Al-Awadhi, F., Hurn, M. and Jennison, C., 2004. Improving the acceptance rate of reversible jump MCMC proposals.

*Statistics & Probability Letters*, 69 (2), pp. 189-198.Yong, P. F. K., Milner, P. C., Payne, J. N., Lewis, P. A. and Jennison, C., 2004. Inequalities in access to knee joint replacements for people in need.

*Annals of the Rheumatic Diseases*, 63 (11), pp. 1483-1489.Milner, P. C., Payne, J. N., Stanfield, R. C., Lewis, P. A., Jennison, C. and Saul, C., 2004. Inequalities in accessing hip joint replacement for people in need.

*European Journal of Public Health*, 14 (1), pp. 58-62.Jennison, C. and Turnbull, B. W., 2003. Mid-course sample size modification in clinical trials based on the observed treatment effect.

*Statistics in Medicine*, 22 (6), pp. 971-993.Leonard, L., Williamson, D. M., Ivory, J. P. and Jennison, C., 2003. An evaluation of the safety and efficacy of simultaneous bilateral total knee arthroplasty.

*Journal of Arthroplasty*, 18 (8), pp. 972-978.Robert, C. P., Meng, X. L., Moller, J., Rosenthal, J. S., Jennison, C., Hurn, M. A., Al-Awadhi, F., McCullagh, P., Andrieu, C., Doucet, A., Dellaportas, P., Papageorgiou, I., Ehlers, R. S., Erosheva, E. A., Fienberg, S. E., Forster, J. J., Gill, R. C., Friel, N., Green, P., Hastie, D., King, R., Kunsch, H. R., Lazar, N. A. and Osinski, C., 2003. Efficient construction of reversible jump Markov chain Monte Carlo proposal distributions - Discussion on the paper by Brooks, Giudici and Roberts.

*Journal of the Royal Statistical Society, Series B (Statistical Methodology)*, 65, pp. 39-55.Arjas, E., Jennison, C., Dawid, A. P., Cox, D. R., Cowell, R. G., Didelez, V., Gill, R. D., Kadane, J. B. and Robins, J. M., 2003. Optimal dynamic treatment regimes - Discussion on the paper by Murphy.

*Journal of the Royal Statistical Society, Series B (Statistical Methodology)*, 65, pp. 355-366.Barber, S. and Jennison, C., 2002. Optimal asymmetric one-sided group sequential tests.

*Biometrika*, 89 (1), pp. 49-60.Molchanov, I., Jennison, C., Ersboll, B. K., Hancock, E., Wilson, R., Horgan, G., Kent, J. T., Ashburner, J., Dryden, I. L., Petrou, M., Angulo, J. M., Berman, M., Coleman, R., Duta, N., Jain, A. K., Ghosh, J. K., Murthy, C. A., Gray, A., Gustafsson, J., Rudemo, M., Hogg, D., Koch, I., Linney, A., Ramsay, J. O., Ramsay, T. O., Rao, M. M., Sebastiani, G., de Souza, K., Sun, C. M., Buckley, M., Titterington, D. M., Trubuil, A., Worsley, K. J. and Yu, K. M., 2001. A penalized likelihood approach to image warping - Discussion.

*Journal of the Royal Statistical Society, Series B (Statistical Methodology)*, 63, pp. 492-514.Jennison, C. and Turnbull, B. W., 2001. On group sequential tests for data in unequally sized groups and with unknown variance.

*Journal of Statistical Planning and Inference*, 96 (1), pp. 263-288.Jennison, C. and Turnbull, B. W., 2000.

*Group sequential tests with applications to clinical trials.*Chapman Hall/CRC.Jennison, C. and Turnbull, B. W., 1997. Group-sequential analysis incorporating covariate information.

*Journal of the American Statistical Association*, 92 (440), pp. 1330-1341.